1. |
Adams TD, Davidson LE, Litwin SE, et al. Health benefits of gastric bypass surgery after 6 years. JAMA, 2012, 308(11): 1122-1131.
|
2. |
Stano S, Alam F, Wu L, et al. Effect of meal size and texture on gastric pouch emptying and glucagon-like peptide 1 after gastric bypass surgery. Surg Obes Relat Dis, 2017, 13(12): 1975-1983.
|
3. |
Mingrone G, Nolfe G, Gissey G C, et al. Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion. Diabetologia, 2009, 52(5): 873-881.
|
4. |
Chen WJ, Wang LX, Wang YP, et al. Exendin-4 protects MIN6 cells from t-BHP-induced apoptosis via IRE1-JNK-caspase-3 signaling. Int J Endocrinol, 2012, 2012: 549081.
|
5. |
Xiong SW, Cao J, Liu XM, et al. Effect of modified Roux-en-Y gastric bypass surgery on GLP-1, GIP in patients with type 2 diabetes mellitus. Gastroenterol Res Pract, 2015, 2015: 625196.
|
6. |
Liu XY, Liu SP, Jiang J, et al. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein. Eur Rev Med Pharmacol Sci, 2016, 20(6): 1098-1108.
|
7. |
Nance K, Eagon JC, Klein S, et al. Effects of sleeve gastrectomy vs. Roux-en-Y gastric bypass on eating behavior and sweet taste perception in subjects with obesity. Nutrients, 2017, 10(1): pii: E18.
|
8. |
Williams DL. Minireview: finding the sweet spot: peripheral versus central glucagon-like peptide 1 action in feeding and glucose homeostasis. Endocrinology, 2009, 150(7): 2997-3001.
|
9. |
Hotamisligil GS. Inflammation and metabolic disorders. Nature, 2006, 444(7121): 860-867.
|
10. |
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med, 2012, 366(17): 1577-1585.
|
11. |
Isbell JM, Tamboli RA, Hansen EN, et al. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care, 2010, 33(7): 1438-1442.
|
12. |
Araki E, Oyadomari S, Mori M. Impact of endoplasmic reticulum stress pathway on pancreatic beta-cells and diabetes mellitus. Exp Biol Med (Maywood), 2003, 228(10): 1213-1217.
|
13. |
Wang H, Kouri G, Wollheim CB. ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity. J Cell Sci, 2005, 118(Pt 17): 3905-3915.
|
14. |
Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med, 2007, 357(8): 753-761.
|
15. |
Clements RH, Gonzalez QH, Long CI, et al. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-Ⅱ diabetes mellitus. Am Surg, 2004, 70(1): 1-4.
|
16. |
Pournaras DJ, Osborne A, Hawkins SC, et al. Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg, 2010, 252(6): 966-971.
|
17. |
Laferrère B. Do we really know why diabetes remits after gastric bypass surgery? Endocrine, 2011, 40(2): 162-167.
|
18. |
Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care, 2008, 31(Suppl 2): S290-S296.
|
19. |
Allen RE, Hughes TD, Ng JL, et al. Mechanisms behind the immediate effects of Roux-en-Y gastric bypass surgery on type 2 diabetes. Theor Biol Med Model, 2013, 10: 45.
|
20. |
Ozcan U, Cao Q, Yilmaz E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science, 2004, 306(5695): 457-461.
|
21. |
Wang LX, Wang YP, Chen Z, et al. Exendin-4 protects murine pancreatic β-cells from dexamethasone-induced apoptosis through PKA and PI-3K signaling. Diabetes Res Clin Pract, 2010, 90(3): 297-304.
|
22. |
Lee WJ, Chong K, Aung L, et al. Metabolic surgery for diabetes treatment: sleeve gastrectomy or gastric bypass? World J Surg, 2017, 41(1): 216-223.
|
23. |
Alamuddin N, Vetter ML, Ahima RS, et al. Changes in fasting and prandial gut and adiposity hormones following vertical sleeve gastrectomy or Roux-en-Y gastric bypass: an 18-month prospective study. Obes Surg, 2017, 27(6): 1563-1572.
|
24. |
Verheij M, Bose R, Lin XH, et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature, 1996, 380(6569): 75-79.
|
25. |
Nakagawa A, Satake H, Nakabayashi H, et al. Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells. Auton Neurosci, 2004, 110(1): 36-43.
|